These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 2896142)

  • 1. [Definition, significance and measurement of disease concepts of patients. The Disease Concept Scale for schizophrenic patients].
    Linden M; Nather J; Wilms HU
    Fortschr Neurol Psychiatr; 1988 Feb; 56(2):35-43. PubMed ID: 2896142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subjective illness theory and antipsychotic medication compliance by patients with schizophrenia.
    Holzinger A; Loffler W; Muller P; Priebe S; Angermeyer MC
    J Nerv Ment Dis; 2002 Sep; 190(9):597-603. PubMed ID: 12357093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Caregiver burden in relatives of persons with schizophrenia: an overview of measure instruments].
    Reine G; Lancon C; Simeoni MC; Duplan S; Auquier P
    Encephale; 2003; 29(2):137-47. PubMed ID: 14567165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Illness concepts of patients].
    Linden M
    Psychiatr Prax; 1985 Jan; 12(1):8-12. PubMed ID: 3983293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Schizophrenia: attitudes of patients and professional carers towards the illness and antipsychotic medication.
    Rettenbacher MA; Burns T; Kemmler G; Fleischhacker WW
    Pharmacopsychiatry; 2004 May; 37(3):103-9. PubMed ID: 15138893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Insight in schizophrenia: assessment of 31 patients with different scales].
    Travers D; Levoyer D; Millet B
    Encephale; 2008 Jan; 34(1):66-72. PubMed ID: 18514153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [On the "folkloric" psychotherapy to schizophrenic patients--based on phenomenological study].
    Yamada T; Yamada Y
    Seishin Shinkeigaku Zasshi; 1998; 100(6):369-86. PubMed ID: 9745352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [What information do patients with schizophrenia have about their illness and treatment?].
    Ferreri M; Rouillon F; Nuss P; Bazin N; Farah S; Djaballah K; Gerard D
    Encephale; 2000; 26(5):30-8. PubMed ID: 11192802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychometric properties of the Subjective Well-Being Under Neuroleptics scale and the Subjective Deficit Syndrome Scale.
    de Haan L; Weisfelt M; Dingemans PM; Linszen DH; Wouters L
    Psychopharmacology (Berl); 2002 Jun; 162(1):24-8. PubMed ID: 12107613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship between insight and symptoms in schizophrenia.
    Sevy S; Nathanson K; Visweswaraiah H; Amador X
    Compr Psychiatry; 2004; 45(1):16-9. PubMed ID: 14671732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Zotepine versus placebo in the treatment of schizophrenic patients with stable primary negative symptoms: a randomized double-blind multicenter trial.
    Möller HJ; Riedel M; Müller N; Fischer W; Kohnen R
    Pharmacopsychiatry; 2004 Nov; 37(6):270-8. PubMed ID: 15551193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The origin of informed consent].
    Mallardi V
    Acta Otorhinolaryngol Ital; 2005 Oct; 25(5):312-27. PubMed ID: 16602332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The differentiation between 'lack of insight' and 'dysfunctional health beliefs' in schizophrenia.
    Linden M; Godemann F
    Psychopathology; 2007; 40(4):236-41. PubMed ID: 17396050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medication and psychotherapy in the treatment of chronic schizophrenia.
    Sarti P; Cournos F
    Psychiatr Clin North Am; 1990 Jun; 13(2):215-28. PubMed ID: 1972273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Psychometric properties of PANSS (Positive and Negative Syndrome Scale) in the French version in a sample of schizophrenic patients].
    Lançon C; Auquier P; Llorca PM; Martinez JL; Bougerol T; Scotto JC
    Encephale; 1997; 23(1):1-9. PubMed ID: 9172961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacophilia and pharmacophobia: determinants of patients' attitudes towards antipsychotic medication.
    Sibitz I; Katschnig H; Goessler R; Unger A; Amering M
    Pharmacopsychiatry; 2005 May; 38(3):107-12. PubMed ID: 15902579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Validation of the Temporal Experience of Pleasure Scale (TEPS) in a French-speaking environment].
    Favrod J; Ernst F; Giuliani F; Bonsack C
    Encephale; 2009 Jun; 35(3):241-8. PubMed ID: 19540410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ["I am a Misunderstood Being on Earth" - Concept of illness of patients suffering from schizophrenic psychosis before and after psychoeducational treatment].
    Hofer E; Wancata J; Amering M
    Psychiatr Prax; 2001 Sep; 28(6):287-91. PubMed ID: 11533896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prognostic and therapeutic relevance of cognitive characteristics for the long-term course of schizophrenic illness following psychoeducational psychotherapeutic treatment].
    Feldmann R; Buchkremer G; Hornung WP
    Fortschr Neurol Psychiatr; 2000 Feb; 68(2):54-60. PubMed ID: 10719658
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.